Creative Biolabs introduces our high-quality in vitro diagnostic (IVD) antibody & new immunoassay development services targeting different disease biomarkers to global clients. Our services are tailor-made and cover all the phases of an immunoassay development process. Here, briefly introduce DCXR as a potential cancer biomarker.

Introduction to DCXR

Dicarbonyl L-xylulose reductase (DCXR) is an evolutionarily conserved metabolic enzyme encoded by the human DCXR gene. It is highly expressed in livers and kidneys of mammals, especially in the epithelial cells of the mouse proximal renal tubule. The enzyme is involved in many intracellular processes, such as glucose metabolism, carbohydrate metabolism, the uronate cycle, and also may play a role in the regulation of the osmotic state of the cellular environment and cellular osmoregulation in the proximal renal tubules by producing xylitol. DCXR has been implicated in many human clinical disorders. Studies have indicated that deficiency of DCXR will cause pentosuria, a historically famous inborn metabolic disease. Furthermore, DCXR is suggested as a biomarker in cancer, and also to be critical for human sperm maturation and fertility.

DCXR/DHS-21 regulates osmolality in C. elegans. (Kim, et al., 2022)Fig.1 DCXR/DHS-21 regulates osmolality in C. elegans.1

DCXR As A Biomarker for Cancer Diagnosis

It has been proposed that DCXR gene transcripts are significantly higher in malignant melanoma tissues, as well as in prostate, breast, and lung cancers when compared with normal skin or normal tissues of each organ. Also, the decreased membranous expression of DCXR with altered subcellular localization appears to be associated with the malignant progression of melanocytic lesions and a poor prognosis for hepatocellular carcinoma patients. Besides, DCXR shows a 4.3-fold upgraded change in the follicular adenoma that makes it an important biomarker for monitoring follicular adenoma in clinic management in case it develops into follicular carcinoma.

IVD Antibody & Immunoassay Development Services Provided by Creative Biolabs

Creative Biolabs offers contract IVD antibody & immunoassay development services to global clients. Specifically, we offer antigen production, antibody production and characterization, protein labeling, immunoassay development, and manufacturing services. If you need a test system tailored to your research or diagnostic needs, we are the perfect match. For more information, please click the links below:

Workflow-for-production-of-an-Immunoassay. (Creative Biolabs Original)

Please feel free to contact us for more information and discuss your project needs. Our customized solutions allow us to offer all the components necessary to develop the most suitable assay for your company.

Reference

  1. Kim, Yuh-Nam, et al. "Dicarbonyl/L-xylulose reductase (DCXR) producing xylitol regulates egg retention through osmolality control in Caenorhabditis elegans." Animal Cells and Systems 26.5 (2022): 223-231.

For Research Use Only.



Online Inquiry
Name:
*Phone:
*E-mail Address:
*Service & Products Interested:
Project Description:
Contact Us USA

Tel:
Fax:
Email:
UK

Tel:
Email:

Germany

Tel:
Email:

Follow us on:
Copyright © 2024 Creative Biolabs.
Inquiry Basket